Bioceptive Inc is categorized under Research and Development Laboratories in New Orleans, LA and active since 2010.
Bioceptive Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Stewart Davis at the company’s single location by writing to 1441 Canal St # 228, New Orleans, Louisiana LA 70112 or by phoning (504) 598-5232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bioceptive Inc |
| Contact Person: | Stewart Davis |
| Address: | 1441 Canal St # 228, New Orleans, Louisiana 70112 |
| Phone Number: | (504) 598-5232 |
| Website Address: | bioceptive.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Bioceptive Inc was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stewart Davis for inquiries that concern Bioceptive Inc by calling the company number (504) 598-5232, as your correspondence is most welcome. Additionally, the physical location of the single location of Bioceptive Inc can be found at the coordinates 29.957318,-90.074698 as well as the street address 1441 Canal St # 228 in New Orleans, Louisiana 70112.
For its online presence, you may visit Bioceptive Inc’s website at bioceptive.com and engage with its social media outlets through on Twitter and on Facebook.